U.S. Stock News

NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Telix-Regeneron Radiopharma Deal and Lawsuit Could Be A Game Changer For Regeneron Pharmaceuticals (REGN)

In July 2026, Telix Pharmaceuticals announced it had entered a collaboration with Regeneron Pharmaceuticals to co-develop and commercialize next-generation radiopharmaceutical cancer therapies, with Telix receiving an initial non-refundable US$40 million payment on signing. Soon after, Regeneron was hit with a securities class action lawsuit alleging misleading disclosures about a Phase III Fianlimab-Libtayo trial, highlighting legal and credibility questions around its oncology pipeline...
NYSE:CALY
NYSE:CALYLeisure

Is Callaway Golf’s (CALY) Discount-Driven Momentum Strengthening or Straining Its Earnings Story?

Recently, Callaway Golf drew attention after analysts gave it a top Zacks Rank, reflecting a stronger earnings outlook and momentum versus Consumer Discretionary peers. The debate now centers on whether discount-driven traffic can support healthier long-term margins, raising fresh questions about the durability of its improving fundamentals. With this in mind, we'll explore how the upgraded earnings outlook, despite margin concerns, reshapes Callaway Golf's broader investment...
NYSE:PKG
NYSE:PKGPackaging

Packaging Corporation of America (PKG) Is Up 9.1% After Record Shipments And Dividend Hike Has The Bull Case Changed?

Packaging Corporation of America recently reported past second-quarter 2026 results, with sales rising to US$2,489.9 million while net income eased to US$192.1 million, leading to lower earnings per share than a year earlier. Alongside record corrugated shipments and early benefits from the Greif containerboard acquisition, the company also announced a containerboard price increase and a sharply higher dividend, underscoring management’s confidence in its operating momentum. Now we’ll...
NYSE:BAC
NYSE:BACBanks

How Investors May Respond To Bank of America (BAC) Dividend Hike Backed By Higher Quarterly Earnings

Bank of America recently raised its regular quarterly common stock dividend to US$0.32 per share, a US$0.04 increase, and reported second-quarter 2026 net income of US$9,074 million on net interest income of US$15,997 million, both higher than a year earlier. This higher shareholder payout, alongside improved credit costs with net charge-offs easing to US$1,412 million, underscores how the bank is balancing capital returns with loan portfolio risk management. Next, we’ll explore how this...
NasdaqGS:BANR
NasdaqGS:BANRBanks

Is Banner (BANR) A Bargain After Its Q2 2026 Earnings And Dividend Update?

Banner (BANR) is back on investors’ radar after its second quarter 2026 earnings report and dividend affirmation. The update offers fresh data on profitability, shareholder payouts and how the regional bank is positioned today. See our latest analysis for Banner. Banner’s 12.52% year to date share price return and 11.55% total shareholder return over the past year point to steady momentum. The 64.32% three year total shareholder return highlights how longer term holders have been rewarded as...
NYSE:MAN
NYSE:MANProfessional Services

ManpowerGroup (MAN) Earnings Turnaround Keeps Valuation Questions In Play

What the latest ManpowerGroup earnings mean for investors ManpowerGroup (MAN) is back in focus after the company moved from a net loss a year ago to net income in the second quarter of 2026, while also issuing fresh third quarter earnings guidance. The company reported second quarter net income of US$53.5 million and outlined an expected diluted earnings per share range of US$0.96 to US$1.06 for the upcoming quarter, including an estimated 2 cent currency headwind. See our latest analysis for...
NYSE:PM
NYSE:PMTobacco

Philip Morris International (PM) Gets FDA Backing For ZYN On Fair Value Stays In Focus

The U.S. Food and Drug Administration has granted Philip Morris International (PM) permission to market its ZYN nicotine pouches as modified risk tobacco products, marking the first such designation for smoke free pouches in the U.S. See our latest analysis for Philip Morris International. For investors, this FDA milestone comes during a strong period for Philip Morris International, with a 19.95% 90 day share price return and a 143.58% five year total shareholder return. This suggests that...
NYSE:DEA
NYSE:DEAOffice REITs

Has Easterly Government Properties (DEA) Run Too Far Ahead Of Its Valuation?

Easterly Government Properties (DEA) is drawing investor interest after recent share price moves, with the stock last closing at $25.33. This price puts the government-focused REIT’s market value at about $1.30b. See our latest analysis for Easterly Government Properties. Over the past year, Easterly Government Properties has combined an 18.86% year-to-date share price return with a 20.11% total shareholder return. The 3-year and 5-year total shareholder returns are 10.78% and 35.31% lower,...
NYSE:RF
NYSE:RFBanks

Regions Financial (RF) After Strong Earnings And A Dividend Hike Looks Modestly Undervalued

Regions Financial earnings and dividend move into focus Regions Financial (RF) is back on investors’ radar after reporting second quarter 2026 results that included modestly higher net interest income and net income, paired with a 13% increase in its quarterly common dividend. See our latest analysis for Regions Financial. Regions Financial’s recent earnings, dividend uplift and completed share buyback have arrived alongside an 11.97% year to date share price return and a 21.48% total...
NYSE:ONON
NYSE:ONONLuxury

Palantir Stock And 2 Cash Flow Picks Trading Below Fair Value

Global markets are wrestling with higher energy costs, uneven growth signals, and central banks that are hesitant to move too quickly on interest rates. In this kind of mixed backdrop, investors often look for companies where the cash being generated by the business is not fully reflected in the share price. The Undervalued Stocks Based On Cash Flows screener focuses exactly on that and highlights stocks that SWS DCF valuation suggests are trading below their fair value. In this article, you...
NYSE:GWRE
NYSE:GWRESoftware

Is Guidewire (GWRE) Quietly Reframing Its Cloud‑and‑AI Story With New Board and ProNavigator Moves?

Guidewire Software, Inc. announced that Alexander Vollert joined its Board of Directors on August 1, 2026, bringing extensive senior insurance and technology leadership experience from AXA and Allianz. In parallel, Germania Mutual Insurance Company adopted Guidewire’s ProNavigator AI assistant for underwriting and claims, highlighting how insurers are embedding Guidewire’s AI directly into everyday workflows on its core platform. We’ll now examine how Germania Mutual’s rollout of...
NasdaqGS:MPLT
NasdaqGS:MPLTBiotechs

MapLight Therapeutics (MPLT) Rally Puts Its CNS Story And Valuation In Focus

MapLight Therapeutics (MPLT) has drawn investor attention recently as its clinical-stage central nervous system pipeline, including candidates for schizophrenia, Alzheimer’s disease psychosis and Parkinson’s disease, trades around $36.56 with a market value near $1.66 billion. See our latest analysis for MapLight Therapeutics. For context, MapLight Therapeutics’ share price return has been strong over 2024, with a year to date gain of 118.01% and a 90 day share price return of 19.32%...
NYSE:LPX
NYSE:LPXBuilding

Louisiana-Pacific (LPX) Leans On Housing Repair Demand, Is The Stock Still A Bargain?

How Louisiana-Pacific Stock Has Been Trading Recently Louisiana-Pacific (LPX) has seen mixed share performance recently, with the stock up 3.2% over the past day and slightly higher over the past week, but down over the past month and over the past three months. See our latest analysis for Louisiana-Pacific. At a share price of $74.48, Louisiana-Pacific has seen a 1-year total shareholder return that is down 15.9%, while the 5-year total shareholder return of 43.72% points to a much stronger...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

FDA Acceptance of AXS-12 NDA for Narcolepsy Might Change The Case For Investing In Axsome (AXSM)

Axsome Therapeutics recently reported that the FDA accepted for filing its New Drug Application for AXS-12 (reboxetine) to treat cataplexy in narcolepsy, with a Prescription Drug User Fee Act target action date set for May 1, 2027, and no advisory committee meeting currently planned. This regulatory milestone advances Axsome’s late-stage pipeline in a serious orphan neurological condition, potentially reinforcing the company’s focus on differentiated central nervous system therapies. We’ll...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Zevra Therapeutics (ZVRA) Is Down 25.4% After EMA Rejects Arimoclomol MAA In NPC Re-Examination Bid

In July 2026, Zevra Therapeutics reported that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative opinion on the Marketing Authorization Application for arimoclomol in Niemann-Pick disease type C, prompting the company to seek a formal re-examination while maintaining patient access through its global Expanded Access Program. The updated international Consensus Clinical Management Guidelines for Niemann-Pick disease type C highlight arimoclomol...
NYSE:GWW
NYSE:GWWTrade Distributors

W.W. Grainger (GWW) Stock Looks Overvalued On Cash Flow And Earnings

W.W. Grainger stock has delivered a very strong 227.4% return over the past five years, yet current checks suggest investors are now paying a premium, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to an overvalued share price. A 227.4% five year return highlights how strongly W.W. Grainger has rewarded long term shareholders and raises the bar for what future performance needs to justify today’s price. Expectations for continued profit growth...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Holdings (MARA) Could Be 33% Undervalued As HPC Plans And Earnings Near

MARA Holdings (MARA) is back in focus after recent moves to repurpose some Bitcoin mining sites for high performance computing, continued Bitcoin sales to reduce debt, and rising attention ahead of its upcoming earnings report. See our latest analysis for MARA Holdings. MARA Holdings’ recent repurposing of mining sites toward high performance computing, continued Bitcoin sales to reduce debt, and attention around the upcoming earnings report have come alongside choppy trading, with a 7 day...
NYSE:MHK
NYSE:MHKConsumer Durables

Is Mohawk Industries (MHK) Undervalued As Its Sustainability Story Meets Softer Demand?

Mohawk Industries (MHK) stock has been moving on recent trading performance, with a gain of about 3% over the past day and a smaller rise across the past week. See our latest analysis for Mohawk Industries. Zooming out, Mohawk Industries’ recent 1 day share price gain sits against a 30 day share price return that is down 5.42%, while the 1 year total shareholder return is down 6.31%. This suggests momentum has softened after a stronger 90 day share price return of 5.28%. If you are comparing...
NasdaqGS:UVSP
NasdaqGS:UVSPBanks

Can Univest Financial (UVSP) Justify Its Valuation As Strong Q2 Results Lift Guidance?

Univest Financial (UVSP) is back on investor radars after reporting second quarter 2026 results, raising its full-year net interest income outlook, and affirming its quarterly dividend. See our latest analysis for Univest Financial. Univest Financial's share price has had a quiet few weeks despite a strong run this year, with the 90 day share price return of 16.88% and 1 year total shareholder return of 54.28% pointing to momentum that has been building rather than fading. If Univest...
NYSE:QTWO
NYSE:QTWOSoftware

Q2 Holdings (QTWO) Rebounds On Digital Banking Demand, Is The Stock Still Cheap?

Q2 Holdings (QTWO) has drawn fresh attention after recent trading, as investors weigh its digital banking focus against a mixed return profile, with gains over the past 3 months and year to date declines. See our latest analysis for Q2 Holdings. The recent move in Q2 Holdings’ share price to US$54.61, with a 30 day share price return of 13.98% and a 90 day gain of 12.46%, contrasts with a year to date decline of 21.35% and a 1 year total shareholder return decline of 38.8%. This suggests that...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Opendoor Technologies (OPEN) Is Down 14.8% After Weak Earnings And Revenue Drop Has The Bull Case Changed?

Opendoor Technologies recently continued to face selling pressure as its shares moved toward recent lows, with technical indicators pointing to weaker momentum ahead of its August 4 earnings release, which ultimately showed a larger loss and a significant revenue decline compared with the prior year. This combination of softening trading signals and concern about operational performance has intensified investor focus on how resilient Opendoor’s business model might be in a more challenging...
NYSE:WCN
NYSE:WCNCommercial Services

Waste Connections (WCN) After Raised Guidance, Is The Valuation Case Still Compelling?

Waste Connections (WCN) is back in focus after reporting second quarter 2026 earnings that topped Wall Street expectations, raising full year revenue and net income guidance while underscoring dividends, buybacks, and new project investments. See our latest analysis for Waste Connections. At a share price of $169.61, Waste Connections has seen a 5.0% share price return over the past 90 days even though the year to date share price return is down 2.6%. The 3 year total shareholder return of...
NYSE:UGI
NYSE:UGIGas Utilities

Utility Stocks for Higher Rates That Still Offer Steady Dividends

With Fed Chair Kevin Warsh signaling higher interest rates are likely to stick and the S&P 500 already up 10% in 2026, many investors are rethinking how they balance income, risk, and rate sensitivity. Stable dividend paying utility stocks sit at the crossroads of those questions, often seen as potential sources of consistent cash flow but also exposed to funding costs and inflation. This article focuses on 3 utility stocks from our Stable Dividend Paying Utility Stocks screener that appear...
NYSE:AEE
NYSE:AEEIntegrated Utilities

How Investors May Respond To Ameren (AEE) Earnings Growth Driven By Regulated Utility And Grid Investments

Ameren released its June-quarter earnings on July 30, highlighting year-over-year growth in earnings and revenue supported by its regulated utility operations. An interesting angle for investors is how regulation-backed earnings and ongoing grid modernization investments are increasingly central to Ameren’s earnings profile. With optimism around regulation-backed earnings ahead of the July 30 release, we’ll now examine how this shapes Ameren’s investment narrative. Rare earth metals are an...